The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis
Keywords: CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease; DPI; dry powder for inhalation; EOS; end of study; EOT; end of treatment; FAS; full analysis set; FEV1; forced expiratory volume in 1Â s; FVC; forced vital capacity; MIC; minimum inhibitory